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New concepts on potassium channel function in neuroinflammation suggest that they
regulate mechanisms of microglial activation, including intracellular calcium homeosta-
sis, morphological alterations, pro-inflammatory cytokine release, antigen presentation,
and phagocytosis. Although little is known about voltage independent potassium chan-
nels in microglia, special attention emerges on small (SK/KCNN1-3/KCa2) and intermediate
(IK/KCNN4/KCa3.1)-conductance calcium-activated potassium channels as regulators of
microglial activation in the field of research on neuroinflammation and neurodegeneration.
In particular, recent findings suggested that SK/KCa2 channels, by regulating calcium home-
ostasis, may elicit a dual mechanism of action with protective properties in neurons and
inhibition of inflammatory responses in microglia. Thus, modulating SK/KCa2 channels and
calcium signaling may provide novel therapeutic strategies in neurological disorders, where
neuronal cell death and inflammatory responses concomitantly contribute to disease pro-
gression. Here, we review the particular role of SK/KCa2 channels for [Ca2+]i regulation
in microglia and neurons, and we discuss the potential impact for further experimen-
tal approaches addressing novel therapeutic strategies in neurological diseases, where
neuronal cell death and neuroinflammatory processes are prominent.
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INTRODUCTION
An increasing number of recent reports on potassium SK/KCa2
and IK/KCa3.1 channels elucidate their multifaceted functions in
cell motility, neuronal excitability, neuroprotection, and neuroin-
flammation (Stocker, 2004; Schlichter et al., 2010; Allen et al.,
2011; Dolga et al., 2011). In fact, based on the plethora of func-
tions exerted by SK/KCa2 channels, modulators of these potassium
channels have been proposed for therapeutic applications in a wide
variety of pathological conditions, including brain tumors, cere-
bral ischemia, schizophrenia, Parkinson’s and Alzheimer’s diseases,
and other neurological diseases where neuroinflammatory mech-
anisms are considered as major hallmarks (see Table 1; Rupalla
et al., 1998; Wyss-Coray and Mucke, 2000; Liégeois et al., 2003;
Yan et al., 2003; Stocker, 2004; Judge et al., 2007; Hirsch and
Hunot, 2009; Schlichter et al., 2010; Allen et al., 2011; Dolga
et al., 2011, 2012; Varas-Lorenzo et al., 2011; Herrik et al., 2012;
Kuiper et al., 2012). For example, riluzole, a drug used in patients
with amyotrophic lateral sclerosis (ALS) and hereditary cerebel-
lar ataxia, is a potent activator of SK/KCa2 channels (Grunnet
et al., 2001; Cao et al., 2002) that reduces neuroinflammation and
neuronal excitability (Judge et al., 2007; Waubant, 2007; Ristori
et al., 2010; Liu et al., 2012; see Table 1). Recently, derivatives of
2-(phenylamino)benzimidazole and 2-amino benzimidazole were
patented as novel SK/KCa2 channel modulators for therapeutic
applications in Alzheimer’s disease, anxiety, and ataxia (Sørensen
et al., 2006a,b).
POTASSIUM CHANNELS IN MICROGLIA
Patch-clamp studies of microglial cells showed that these cells
express a wide variety of potassium channels. These include inward
rectifier K+ (Kir) channels (described in rat, murine, bovine, and
human microglia), delayed outwardly rectifying K+ (Kdr) chan-
nels (described in rat, mouse, and human microglia), human
ether-a-go-go-related gene (HERG) K+ channels (described in rat
microglia), G protein-activated K+ channels, ATP-sensitive potas-
sium (KATP) channels, and voltage independent calcium-activated
potassium (SK/KCa2) channels (described in murine, bovine, and
human microglia; Eder et al., 1997; Eder, 1998). Several studies
demonstrated that microglial potassium channel activity pro-
motes neuronal survival and reduces microglial activation and
related neuroinflammation (Polazzi and Monti, 2010; Kettenmann
et al., 2011). For example, KATP channel activation using diazoxide
exerted anti-inflammatory effects in LPS and interferon gamma
(IFNγ)-activated mouse primary microglial cells in vitro (Virgili
et al., 2011). Diazoxide, a classical KATP channel activator, pre-
vented rotenone-induced rat microglial activation (Zhou et al.,
2008), inhibited NO release, tumor necrosis factor alpha (TNF-α),
interleukin-6 (IL-6) production, and inducible nitric oxide syn-
thase (iNOS) expression in a mouse model for multiple sclerosis in
an induced experimental autoimmune encephalomyelitis (Virgili
et al., 2011).
KCNN3/SK3/Kca2.3 CHANNEL FUNCTION
The expression of all subtypes KCNN1-3/SK1-3/KCa2.1-3 chan-
nels have been described in microglial cells (Kaushal et al., 2007;
Schlichter et al., 2010; Hayashi et al., 2011). However, among
all SK1-3/KCa2.1-3 channel subtypes, the SK3/KCa2.3 channel
subtype plays the most critical role in microglial activation. The
mRNA of SK3/KCa2.3 channels was detected in mouse and rat
microglial cells (Khanna et al., 2001; Dolga et al., 2012) and
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Table 1 |Targeting KCa2.1/KCa2.2/KCa2.3 channels in CNS disorders – patents and clinical trials.
Type of action Compound Diseases/pathological
conditions
Reference
Activation Riluzole Hereditary ataxia, multiple sclerosis,
cerebellar ataxia
Grunnet et al. (2001), Cao et al. (2002),
Ristori et al. (2010), Waubant (2007)
Inhibition 2-(Phenylamino) benzimidazole,
2-amino benzimidazole derivatives
Cerebral ischemia, stroke, AD, ataxia, anxiety,
depression, cognitive disorders, hearing loss
Sørensen et al. (2006a,b), Wang et al. (2003)
Inhibition Pyrazolyl-pyrimidine derivatives Epilepsy, convulsions neuroinflammation Eriksen et al. (2006)
was found significantly up-regulated after LPS stimulation in
rat primary microglial cells (Schlichter et al., 2010). In recent
studies, contributions of SK3/KCa2.3 channels to microglial activa-
tion processes were elucidated using a pharmacological approach
(Schlichter et al., 2010) based on affinities of apamin and tamapin
for cloned SK/KCa2 channels (Pedarzani and Stocker, 2008). In
these experiments, 100 nM apamin or 5 nM tamapin inhibited
the function of SK2/KCa2.2 and SK3/KCa2.3 channels, while the
role for SK3/KCa2.3 channels was deduced when the cellular
microglial functions were compared with tamapin at concentra-
tions of 250 pM that should not inhibit SK3/KCa2.3 channel func-
tion (Schlichter et al., 2010). Using this pharmacological approach,
the authors found that inhibition of SK3/KCa2.3 channels reduced
the neurotoxic effects of activated rat primary microglia.
In the same study, apamin or tamapin reduced LPS-induced
NO release, and decreased the activity of p38-mitogen-activated
protein kinase (MAPK) in microglia cells and attenuated tyrosine-
nitrated proteins in the neurons exposed to activated microglia.
Interestingly, LPS-mediated nuclear factor-kappa B (NF-κB) acti-
vation was not affected by low doses of either apamin or tamapin
(Schlichter et al., 2010).
Furthermore, it has not yet been determined how SK3/KCa2.3
channel modulation regulates microglial activation pathways;
including cytokine release and calcium deregulation and if there
are any species-dependent differences. Since the previous stud-
ies using small molecules or toxins seem to reveal critical roles
of SK3/KCa2.3 channels in microglial activation, studies using
SK/KCa2 channel siRNA or knockout animals are required to
resolve the limitations of these pharmacological approaches.
POTASSIUM KCNN/SK/Kca2 CHANNELS IN NEURONS
All subtypes of small-conductance calcium-activated potassium
KCNN1-3/SK1-3/KCa2.1-3 channels have been identified in neu-
ronal cells of different species, including mouse, rat, and human
neurons (Köhler et al., 1996; Sailer et al., 2004; Dolga et al., 2011).
In neuronal cells, SK/KCa2 channels are activated by submicro-
molar calcium concentrations (K D∼ 0.5µM) due to the calcium
sensing binding site, a calmodulin (CaM)-binding domain located
at the C-terminus of β-subunits (Adelman et al., 2012).
Functional SK/KCa2 channels consist of four subunits, each
with six transmembrane segments and cytosolic N and C termini
(Stocker, 2004). Upon increasing intracellular calcium concen-
trations, CaM interaction to CaM-binding domain (CaMBD)
alters the geometry of the C-lobe E-F hands from one subunit
of SK/KCa2 channels by binding to a neighboring subunit and
forming a dimer that promotes a conformational rotation of
CaMBD, allowing potassium flow through the channel pore (Xia
et al., 1998;Adelman et al., 2012). It is well established that SK/KCa2
channels mediate afterhyperpolarization (AHP) in response to an
action potential in excitable cells. Opening of SK/KCa2 channels
promotes a negative resting membrane potential or even hyperpo-
larizing, preventing the onset of a second action potential. Thus,
SK/KCa2 channels act as fine tuning regulators of action potential
frequencies, neuronal excitability, and [Ca2+]i (Stocker, 2004).
SK/KCa2 channels are responsible for the medium AHP
(mAHP), which decays in 200 ms (Bond et al., 2004), while BK
channels are responsible for the fast AHP component, which
decays in 50 ms (Faber and Sah, 2003). SK/KCa2 channels possess
a small unitary conductance (∼10 pS in symmetrical potassium;
Köhler et al., 1996) and exhibit an inward rectification. The gen-
eral knowledge of the inward rectification of SK/KCa2 channels is
attributed to the block of outward current by divalent ions, such
as Ca2+ and Mg2+ (Lu, 2004), as it is the case for inward rectifier
K+ channels (Kir, IRK). However, it was recently shown by inside-
out patch-clamp recordings of rat SK2/KCa2.2 channel activity
that three negatively charged residues in the sixth transmembrane
domain could also be responsible for the SK/KCa2 channel inward
rectification (Li and Aldrich, 2011). Importantly, these negatively
charged residues affect the Ca2+ affinity for SK/KCa2 channel gat-
ing, and the open probability (Po) of the channel in the absence
of Ca2+ and this intrinsic inward rectification is largely attrib-
uted to a voltage-dependent reduction in outward single-channel
conductance (Li and Aldrich, 2011). However, in specific neurons,
such as in the rat nucleus basalis, in the rat ventral midbrain, or
in preoptic rat hypothalamus, SK/KCa2 channels are responsible
for slow “spontaneous miniature” outward currents (Arima et al.,
2001; Cui et al., 2004; Klement et al., 2010). The precise function
of these outward currents has not yet been elucidated, however, it
has been suggested that they may also contribute to spontaneous
firing, hyperpolarization, and regulation of burst firing (Adelman
et al., 2012).
SK2/Kca2.2 CHANNEL FUNCTION
In hippocampal and cortical mouse neurons, SK2/KCa2.2 chan-
nel subtypes are localized at dendritic spines, where they are
closely associated with NMDA receptors and contribute to
AHP, regulate calcium homeostasis and reduce the amplitude
of evoked synaptic potential in an NMDA receptor-dependent
manner, thereby attenuating neuronal excitability (Faber et al.,
2005; Ngo-Anh et al., 2005). Very little has been reported on
the regulation of SK2/KCa2.2 channel expression under physi-
ological conditions and in disease. The physiological regulatory
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functions of SK2/KCa2.2 receptors on NMDAR function and cal-
cium homeostasis become even more relevant under conditions
of excitotoxic stress. For example, pharmacological activation of
SK2/KCa2.2 receptors attenuates NMDA-mediated intracellular
[Ca2+] increases and excitotoxicity in rat primary cortical neu-
rons (Dolga et al., 2011). In contrast, NMDAR-mediated exci-
totoxicity and cell death is associated with rapid SK2/KCa2.2
down-regulation in both rat and mouse primary neurons (Allen
et al., 2011; Dolga et al., 2011), and such reduced SK2/KCa2.2
protein levels resulted in a failure to regulate neuronal excitabil-
ity. Overall these data point at a pivotal regulative function
of SK2/KCa2.2 channels on NMDAR-dependent calcium home-
ostasis under physiological conditions and suggest a therapeutic
potential in excitotoxic conditions.
Interestingly, two responsive elements of NF-κB were found
in the intronic promoter region of SK2/KCa2.2 channels, suggest-
ing that NF-κB regulates SK2/KCa2.2 channel gene transcription
in rat adrenal medulla PC12 cells (Kye et al., 2007). In acti-
vated microglia, NF-κB signaling and the p38 MAPK pathway
are strongly activated (Koistinaho and Koistinaho, 2002; Mattson,
2005). In addition, TNF-α production is also augmented following
microglial activation (Kettenmann et al., 2011). In mouse primary
cortical neurons, TNF-α facilitates activation of NF-κB signaling,
which in turn may up-regulate SK2/KCa2.2 channel gene tran-
scription in neurons (Dolga et al., 2008). For example, it is not
yet known whether NF-κB activity also modulates SK2/KCa2.2
channel gene transcription in microglial cells. However, in acti-
vated rat primary microglial cells, inhibition of SK/KCa2 channels
by apamin further decreased inhibitory factor κB (IκB-α) lev-
els (Schlichter et al., 2010). These data suggested that inhibition
of SK/KCa2 channels does not affect LPS-induced NF-κB activa-
tion in activated rat primary microglial cells. It is not yet resolved
whether SK2/KCa2.2 channel function is different in various mam-
malian species or whether in activated microglia, the persistent
increase in [Ca2+]i and TNF-α production is associated with
altered SK2/KCa2.2 channel expression and activity.
NEURONAL AND MICROGLIAL PATHWAYS OF SK1-3/Kca2.1-3
CHANNEL ACTIVATION
NEURONAL PATHWAYS
In excitable cells, SK/KCa2 channels are activated by increases in
intracellular calcium after release from several different sources:
Ca2+ influx from the extracellular space via ionotropic recep-
tors, including NMDARs and nicotinic acetylcholine receptors
(nAChRs), Ca2+ influx via voltage-dependent calcium channels
(VDCC, Cav), and Ca2+ release from the intracellular calcium
stores, such as the endoplasmic reticulum (ER; Oliver et al., 2000;
Ngo-Anh et al., 2005). For example, at the dendritic spines of
mouse hippocampal neurons, NMDARs are closely associated
with SK2/KCa2.2 channels (Ngo-Anh et al., 2005). NMDARs-
dependent Ca2+ transients induce excitatory postsynaptic cur-
rents that are followed by SK/KCa2 channel activity in the rat brain
(Faber et al., 2005). While the slow kinetics of the NMDARs does
not provide the major Ca2+ source for SK/KCa2 channel activation
in rat hippocampal brain slices (Sabatini et al., 2002), Ca2+ influx
through α9-nAChRs is direct and more effective in activating
SK/KCa2 channels in the rat basolateral amygdala (Power and Sah,
2008). In the inner and outer hair cells of the rat cochlea, SK/KCa2
channels and nAChRs are functionally coupled and are situated
∼10–20 nm apart (Oliver et al., 2000). SK/KCa2 channels translate
Ca2+ influx through nAChRs inducing an inhibitory postsynap-
tic current that hyperpolarizes the plasma membrane and reduces
action potential frequencies (Oliver et al., 2000). Action potentials
induce Ca2+ influx via VDCC generating fast, large (larger than
micromolar concentrations), and local Ca2+ increases. Activation
of SK/KCa2 channels through VDCC channels is largely attributed
to their proximity to these channels (Fakler and Adelman, 2008).
Further, inositol 1,4,5-triphosphate (IP3) generation via
metabotropic receptor activation is another neuronal Ca2+ source
for SK/KCa2 channel activation. IP3 generation in the presence of
an action potential further promote Ca2+ release from the intra-
cellular stores, such as ER, that in turn activates SK/KCa2 channels
(Power and Sah, 2008). Using whole-cell patch-clamp recordings
and high-speed fluorescence imaging it was shown that muscarinic
acetylcholine receptors (mAChR) agonists promote large rises in
cytosolic calcium via IP3 receptors in the soma and proximal den-
drites of neurons in the rat basolateral amygdala. This calcium
release was associated with activation of an outward current and
hyperpolarization, which resulted from the activation of SK/KCa2
channel (Power and Sah, 2008). The functional relevance of this
SK/KCa2 channel activation was demonstrated in rat midbrain
dopaminergic neurons, in rat cortical neurons, and rat amygdala,
where glutamate and acetylcholine release in response to an action
potential mediated a slow inhibitory postsynaptic potential, largely
attributed to SK/KCa2 channel activation via calcium release from
the IP3 intracellular stores (Fiorillo and Williams, 1998; Morikawa
et al., 2000; Seutin et al., 2000; Faber et al., 2005; Gulledge and
Stuart, 2005).
Another calcium source for SK/KCa2 channel activation is pro-
moted by P/Q-type Ca2+ channel activity and ryanodine receptor
(RyR)-induced Ca2+ release (Adelman et al., 2012). Mutations
in P/Q-type Ca2+ channels are associated with human episodic
ataxia type 2, irregular pacemaking, and reduced firing precision
in mouse Purkinje cells. Reduced activity of P/Q-type Ca2+ chan-
nels is attributed to a decreased mAHP as a consequence of reduced
activity of postsynaptic P/Q-coupled SK/KCa2 channels. Indeed,
in vivo application of the SK/KCa2 channel opener 1-EBIO into the
cerebellum significantly improved the motor coordination deficits,
dyskinesia, and ataxia in the P/Q-type Ca2+ channel mutant mice
(Walter et al., 2006). This particular cross-talk between SK/KCa2
channels and P/Q-type Ca2+ channels is of critical importance in
the cerebellum where together with RyR they cooperate to generate
and maintain AHP (Kakizawa et al., 2007).
MICROGLIAL PATHWAYS
In microglial cells, intracellular calcium signals are modulated by
calcium diffusion through membrane ion channels and by active
and passive transport through calcium pumps and co-transporters
(Kettenmann et al., 2011; Figure 1). Like in all non-excitable cells,
Ca2+ signals in microglia are regulated by Ca2+ release mecha-
nisms from the intracellular stores and by extracellular Ca2+ entry
into the cytosol through membrane-located store-operated Ca2+
(SOC) channels and ligand-gated channels (Kettenmann et al.,
2011). Release of free Ca2+ into the cytosol is mainly attributed to
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FIGURE 1 | Calcium regulation in microglia. Calcium signal
generation is achieved by a well-regulated relationship between Ca2+
release from the intracellular stores and the Ca2+ entry through
plasmalemma. In the ER, sarcoendoplasmic reticulum Ca2+-ATPases
(SERCA) transfer Ca2+ to the lumen of the ER, while the Ca2+ release
from ER into the cytoplasm is accomplished by ryanodine receptors
(RyRs) and inositol 1,4,5-triphosphate (IP3)-gated calcium channels.
Ca2+ also accumulates in mitochondria through a Ca2+-selective
uniporter. Ca2+ extrusion from the cytosol is achieved by a Na+/Ca2+
exchanger.
the dynamic release from intracellular stores, such as ER and mito-
chondria. In the ER, sarcoendoplasmic reticulum Ca2+-ATPases
(SERCA) transfer Ca2+ to the lumen of the ER, while the Ca2+
release from ER into the cytoplasm is accomplished by RyRs and
IP3-gated calcium channels (Verkhratsky and Kettenmann, 1996;
Burdakov et al., 2005; Klegeris et al., 2007).
Although there is no evidence so far for an association between
SK/IK/KCa2/KCa3 channels and RyR receptors in microglia, it
was demonstrated in neurons of the rat and mouse substantia
nigra pars reticulata and the rat medial preoptic nucleus, that
RyR-mediated Ca2+ release from intracellular stores activated
SK2/KCa2.2 and SK3/KCa2.3 channels, respectively (Yanovsky
et al., 2005; Klement et al., 2010). Further, combined electrophys-
iological, immunohistochemical, and two-photon Ca2+ imaging
techniques applied to the rat nucleus reticularis thalami indicated
that calcium-induced calcium release (CICR) via RyRs activated
plasma membrane SK2/KCa2.2 channels, which together with
SERCA pumps and low-voltage-activated Ca2+ channels, shaped
rhythmic [Ca2+]i oscillations (Coulon et al., 2009). In rat smooth
muscle cells, CICR have a critical implication in the regeneration
of the contractile cycle, since Ca2+ release via RyRs facilitates the
activation of IK/KCa3.1 channels, which, in turn, mediates smooth
muscle cell hyperpolarization and relaxation (Haddock and Hill,
2002). Since both RyR receptors and SK/IK/KCa2/KCa3.1 channels
are expressed and functional in microglial cells, research on expres-
sion, and function of KCa channels in the ER requires further
in depth investigation in order to demonstrate their functional
interconnectivity, potential role in the regulation of intracellular
calcium homeostasis, and influence on inflammatory responses in
activated microglia.
Several studies have reported that inflammatory activation pro-
moted dysbalanced calcium homeostasis in microglia (Hoffmann
et al., 2003; Beck et al., 2008; Kettenmann et al., 2011). For exam-
ple, LPS triggered mouse primary microglial activation, NO, and
cytokine release, an increase in [Ca2+]i, and a decrease of calcium
signals in response to UTP and complement factor 5a (Hoffmann
et al., 2003). The critical role of [Ca2+]i in microglial activation
was demonstrated by the intracellular calcium chelator BAPTA-
AM that reverted LPS-induced microglial activation and reduced
the associated NO and cytokine production in both mouse and rat
primary microglia (Hoffmann et al., 2003; Nagano et al., 2006).
Extracellular Ca2+ is likely of major importance for microglial
activation, since depletion of extracellular Ca2+ or EDTA dimin-
ished LPS-induced microglial activation and proliferation in vitro
in mouse primary microglia (Dolga et al., 2012). Interestingly,
an increase in [Ca2+]i is more a facilitator than a trigger of
microglial activation, since, for example, ionomycin increased
[Ca2+]i but it did not induce cytokine or NO releases from
microglia (Hoffmann et al., 2003). Studies addressing the influence
of calcium homeostasis on cell survival pathways demonstrated
that extracellular calcium chelation did not trigger microglial cell
death, whereas increasing [Ca2+]i with ionomycin or thapsigargin
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induced apoptotic cell death (Hoffmann et al., 2003; Nagano et al.,
2006). Furthermore, in LPS-stimulated microglia, thapsigargin
and ionomycin induced necrotic cell death, and these effects were
attenuated by lowering [Ca2+]i with BAPTA-AM (Nagano et al.,
2006). These data suggest that deregulated [Ca2+]i concentration
in activated microglia is critical for cell survival and shifts the mode
of cell death from apoptosis to necrosis (Hoffmann et al., 2003;
Nagano et al., 2006). Better understanding of the consequences
of deregulated intracellular Ca2+ concentration in microglial cells
warrants comprehensive investigation for establishing potential
therapeutic approaches for inflammation-related CNS disorders.
PROTECTIVE ROLE OF SK/Kca2 CHANNELS IN NEURONS AND
MICROGLIA
Several acute and chronic pathologies, including Alzheimer and
Parkinson’s disease, multiple sclerosis, ALS, cerebral ischemia,
and cardiovascular disease are endowed with an inflammatory
component. The function of SK/KCa2 channel in stroke and
Alzheimer’s disease was recently reviewed by Kuiper et al. (2012)
and on atherosclerosis and cardiovascular diseases by Wulff and
colleagues (Wulff et al., 2007; Köhler et al., 2010). Neurode-
generative diseases triggered by neuronal hyperexcitability, pro-
gressive dysregulated Ca2+ homeostasis, and excitotoxic neuronal
death could benefit from small molecules that enhance SK/KCa2
channel activity (Kuiper et al., 2012). Other reviews present
data on opening of endothelial KCa3.1/KCa2.3 channels, which
stimulate endothelium-derived-hyperpolarizing-factor (EDHF)-
mediated arteriolar dilation (Brähler et al., 2009) and lower blood
pressure (Wulff et al., 2007; Köhler et al., 2010). On the other hand,
inhibition of smooth muscle IK/KCa3.1 channels is considered for
the treatment of pathological vascular remodeling and sickle cell
anemia, since IK/KCa3.1 channel inhibition has particular benefi-
cial effects in restenosis disease, atherosclerosis, and autoimmune
encephalomyelitis (Wulff et al., 2007; Köhler et al., 2010).
Further, potassium IK1/SK4/KCa3.1 channels are also under
intense investigation because of their high potential in therapeu-
tic drug development for various pathophysiological conditions,
including sickle cell anemia, pancreatic cancer, arterial resteno-
sis, immune diseases, and CNS inflammation (Jensen et al., 2002;
Köhler et al., 2003; Wulff et al., 2003; Jager et al., 2004). In particu-
lar, IK/KCa3.1 channels are highly expressed in murine microglial
cells (Khanna et al., 2001) and are implicated in the production
of reactive oxygen species, nitric oxide as well as peroxynitrite
and protein tyrosine nitration (Skaper, 2011). Increasing evidence
for beneficial effects of IK/KCa3.1 channel inhibition is mainly
derived from studies using the selective antagonist triarylmethane-
34 (TRAM-34), which does not exert any action on KCNN1-
3/SK1-3/KCa2.1-KCa2.3 channels (Wulff et al., 2000). Interestingly,
TRAM-34 reduces the neurotoxicity mediated by LPS-activated
rat primary microglia, and this effect is associated with dimin-
ished iNOS expression and reduced caspase 3 activation (Kaushal
et al., 2007). TRAM-34 also reduced the degeneration of retinal
ganglion cells after optic nerve transection in adult female Sprague
Dawley rats (Kaushal et al., 2007). It improved locomotor function,
reduced the secretion of TNF-α and interleukin-1β, and dimin-
ished the expression of iNOS in a rodent model of spinal cord
injury (Bouhy et al., 2011). In a rat model of ischemia/reperfusion
stroke, TRAM-34 reduced infarct area by ≈50% as determined
by hematoxylin and eosin staining and improved neurological
deficits related to the secondary inflammatory damage (Chen et al.,
2011).
Neuroinflammation and dysfunction of dopaminergic mid-
brain neurons have been implicated in the etiology of Parkinson’s
disease (Qian et al., 2010; Whitton, 2010). Low-level activity of
dopaminergic neurons and alterations of dopamine release have
been associated with impairment in voluntary movements, work-
ing memory, and reward-based learning (Dunnett and Bjorklund,
1999; Spanagel and Weiss, 1999; Svensson, 2000). Therefore, it
is of paramount importance to identify molecular mechanisms
underlying dopaminergic activity and neurotransmitter release.
During early postnatal development, dopaminergic neurons dis-
play anomalous firing patterns and exhibit spontaneous minia-
ture hyperpolarizations, which are not present in adults (Cui
et al., 2004). These spontaneous hyperpolarizations exhibit out-
ward currents and depend on SK/KCa2 channel regulation, T-type
Ca2+ channel activation, and RyR-dependent Ca2+-induced Ca2+
release in mouse and rat midbrain areas (Wolfart et al., 2001;
Cui et al., 2004). In vivo recordings demonstrated that adult rat
dopaminergic neurons exhibit either a single-spike pacemaker in
a burst firing pattern or show irregular firing patterns (Wilson
et al., 1977; Grace and Bunney, 1984), while in vitro recordings
in rat dopamine neurons demonstrated a regular, low-frequency
pacemaker activity (Grace and Onn, 1989). These discrepancies
between in vitro and in vivo recordings reside in a particular type
of synaptic activity able to switch dopaminergic neurons into burst
firing (Cui et al., 2004).
SK/KCa2 channels are emerging candidates to control NMDAR
activation (Ping and Shepard, 1996), GABA receptor-mediating
inhibitory activities (Yanovsky et al., 2005) and postsynaptic con-
ductances in dopaminergic neurons. In fact, a subtype of SK/KCa2
channels, SK3/KCa2.3 subtype was shown to be expressed in
mouse, rat, and guinea pig dopaminergic neurons (Wolfart et al.,
2001; Bosch et al., 2002; Sarpal et al., 2004; Benítez et al., 2011).
The function of SK3/KCa2.3 channels was addressed in mouse
dopaminergic neurons of the substantia nigra, where they regu-
late the frequency and precision of pacemaker spiking (Wolfart
et al., 2001). However, SK3/KCa2.3 channels were not found in
a subpopulation of mouse dopaminergic neurons in the ven-
tral tegmental area (Wolfart et al., 2001), suggesting that these
significant differences in the density of apamin-binding sites in
dopaminergic neurons might be responsible for the functional
differences between ventral tegmental area (A10) and substan-
tia nigra (A9; Grenhoff et al., 1988). Recently, immune-electron
microscopy established also the presence of SK2/KCa2.2 chan-
nel subtype in mouse dopaminergic neurons (Deignan et al.,
2012). SK2/KCa2.2 channels are expressed exclusively in the den-
drites of dopaminergic neurons, while SK3/KCa2.3 channels are
expressed in the soma and, to a lesser extent, in the dendritic
neuronal network. To gain further knowledge of the precise func-
tion of SK/KCa2 channels in dopaminergic neurons, experiments
performed in subtype specific null mice have demonstrated that
SK2/KCa2.2-containing channels are responsible for the precision
of action potential timing, while SK3/KCa2.3-containing channels
contribute to action potential frequencies (Deignan et al., 2012).
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Indeed, modulation of SK/KCa2 channels was shown to regulate
the excitability of rat midbrain neurons (Ji et al., 2009). Positive
SK/KCa2 channel modulation using a non-specific SK/KCa2 chan-
nel subtype compound, NS309 (Strøbaek et al., 2004) decreased
the responsiveness of rat dopaminergic neurons to depolarizing
currents, enhanced spike frequency adaptation, and slowed spon-
taneous firing, due to an increase in the amplitude and duration
of AHP (Ji et al., 2009).
Further, CyPPA, a positive modulator of SK2/KCa2.2 and
SK3/KCa2.3 channel subtypes (Hougaard et al., 2007), decreases
spontaneous firing rate and increases the duration of the
apamin-sensitive AHP, causing an activity-dependent inhibition
of current-evoked action potentials in both mouse and rat mid-
brain slices via SK3/KCa2.3 channel activation (Herrik et al., 2012).
Although CyPPA repressed dopamine release in a concentration-
dependent manner in vivo systemic administration of CyPPA
attenuated methylphenidate-induced hyperactivity and stereo-
typic behaviors in mice (Herrik et al., 2012). In vitro studies
further demonstrated that CyPPA prevented neuronal loss in
an AMPA-dependent toxicity model in rat dopaminergic neu-
rons (Benítez et al., 2011). In contrast, negative pharmacological
modulation by NS8593 (Strøbaek et al., 2006), a non-specific
SK/KCa2 channel subtype compound increased rat dopamin-
ergic excitability, induced an irregular pacemaker and burst-
ing discharge (Ji et al., 2009) and reduced the number of rat
dopaminergic neurons in a dose-dependent manner (Benítez et al.,
2011).
Taken together, modulation of SK/KCa2 channels in dopamin-
ergic neurons regulates neuronal excitability, survival, and neuro-
transmitter release, making them suitable candidates for therapeu-
tic intervention in pathological conditions related to dopaminergic
dysfunction, such as Parkinson’s disease.
Disturbed Ca2+ homeostasis is one of the major causes of
delayed cell death and infarct development after acute brain dam-
age, e.g., after cerebral ischemia. Consequently, reducing intra-
cellular [Ca2+]i levels by blocking NMDA receptors has been
widely investigated in experimental and clinical stroke studies.
However, inhibitors of NMDA receptors largely failed in clin-
ical studies and, therefore, novel strategies controlling [Ca2+]i
homeostasis are warranted for the development of effective ther-
apies. An alternative approach avoiding direct NMDA receptor
targeting would be to modulate [Ca2+]i homeostasis indirectly
via [Ca2+]i sensors, such as KCa channels. Earlier studies showed
that pyramidal cells from the CA3 area of the rat hippocampus
respond to chemical-induced ischemia with an initial transient
hyperpolarization that is responsible for delayed neuroprotective
effects (Tanabe et al., 1999). A potential neuroprotective role for
SK/KCa2 channels was identified when apamin-sensitive SK/KCa2
conductance channels were activated and generated a pronounced
outward current in response to brief ischemia in rat hippocampal
organotypic slice cultures (Tanabe et al., 1999). Indeed, activation
of SK2/KCa2.2 channels by NS309 or 1-EBIO positive modulators
decreased brain damage area (Allen et al., 2011; Dolga et al., 2011)
and also regulated calcium homeostasis (Dolga et al., 2011). In
addition, SK2/KCa2.2 channel activation is required for neuropro-
tection in neurons against glutamate-induced excitotoxicity and
also in vivo in a mouse model of middle cerebral artery occlusion
(MCAo; Allen et al., 2011; Dolga et al., 2011).
SUMMARY AND PERSPECTIVES
Neuroinflammation is a critical component for the initiation
and progression of several neurodegenerative pathologies, such
as cerebral ischemia, schizophrenia, Parkinson’s, and Alzheimer’s
diseases. Potential therapeutic approaches directed against both
inflammation and neuronal degeneration might benefit from
modulation of SK/IK/KCa channels since SK/KCa2 channel activ-
ity elicits a dual mechanism of action with direct protective
effects in neuronal cells and inhibition of inflammatory activi-
ties in microglial cells. However, the role of SK/IK/KCa channels
in microglial activity and maintenance needs further in depth
investigation in order to reveal the culpable molecular mecha-
nisms. It is of interest to determine whether SK/IK/KCa channels
are endowed with similar characteristics among different species,
whether their activity alters during aging or during the progres-
sion of neurodegeneration, and whether modulating SK/IK/KCa
channel activity can limit neurodegeneration and related neu-
roinflammation. Altogether, the hitherto accumulated evidence
exposes modulation of SK/IK/KCa channel functions as poten-
tial target in neurodegenerative diseases where inflammatory
processes significantly contribute to the progress of neuronal
dysfunction.
ACKNOWLEDGMENTS
We thank Emma Jane Esser and Goutham K Ganjam for editing
of the manuscript. This work was partly supported by a grant of
the Alzheimer Forschung Initiative e.V.
REFERENCES
Adelman, J. P., Maylie, J., and Sah,
P. (2012). Small-conductance Ca2+-
activated K+ channels: form and
function. Annu. Rev. Physiol. 74,
245–269.
Allen, D., Nakayama, S., Kuroiwa, M.,
Nakano, T., Palmateer, J., Kosaka,
Y., et al. (2011). SK2 channels
are neuroprotective for ischemia-
induced neuronal cell death. J.
Cereb. Blood Flow Metab. 31,
2302–2312.
Arima, J., Matsumoto, N., Kishimoto,
K., and Akaike, N. (2001). Spon-
taneous miniature outward cur-
rents in mechanically dissociated rat
Meynert neurons. J. Physiol. 534,
99–107.
Beck, A., Penner, R., and Fleig,
A. (2008). Lipopolysaccharide-
induced down-regulation of
Ca2+ release-activated Ca2+
currents (I CRAC) but not Ca2+-
activated TRPM4-like currents
(I CAN) in cultured mouse
microglial cells. J. Physiol. 586,
427–439.
Benítez, B. A., Belálcazar, H. M.,
Anastasía, A., Mamah, D. T., Zorum-
ski, C. F., Mascó, D. H., et al.
(2011). Functional reduction of
SK3-mediated currents precedes
AMPA-receptor-mediated excito-
toxicity in dopaminergic neurons.
Neuropharmacology 60, 1176–1186.
Bond, C. T., Herson, P. S., Strass-
maier, T., Hammond, R., Stack-
man, R., Maylie, J., et al. (2004).
Small conductance Ca2+-activated
K+ channel knock-out mice reveal
the identity of calcium-dependent
afterhyperpolarization currents. J.
Neurosci. 24, 5301–5306.
Bosch, M. A., Kelly, M. J., and
Rønnekleiv, O. K. (2002). Distrib-
ution, neuronal colocalization, and
17beta-E2 modulation of small con-
ductance calcium-activated K(+)
channel (SK3) mRNA in the
guinea pig brain. Endocrinology 143,
1097–1007.
Frontiers in Pharmacology | Neuropharmacology November 2012 | Volume 3 | Article 196 | 6
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dolga and Culmsee SK/IK channels in microglia and neurons
Bouhy, D., Ghasemlou, N., Lively,
S., Redensek, A., Rathore, K. I.,
Schlichter, L. C., et al. (2011). Inhi-
bition of the Ca2+-dependent K+
channel, KCNN4/KCa3.1, improves
tissue protection and locomotor
recovery after spinal cord injury. J
Neurosci. 31, 16298–16308.
Brähler, S., Kaistha, A., Schmidt, V. J.,
Wölfle, S. E., Busch, C., Kaistha,
B. P., et al. (2009). Genetic deficit
of SK3 and IK1 channels disrupts
the endothelium-derived hyperpo-
larizing factor vasodilator pathway
and causes hypertension. Circulation
119, 2323–2332.
Burdakov, D., Petersen, O. H., and
Verkhratsky, A. (2005). Intralumi-
nal calcium as a primary regulator
of endoplasmic reticulum function.
Cell Calcium 38, 303–310.
Cao, Y. J., Dreixler, J. C., Couey, J. J.,
and Houamed, K. M. (2002). Mod-
ulation of recombinant and native
neuronal SK channels by the neu-
roprotective drug riluzole. Eur. J.
Pharmacol. 449, 47–54.
Chen, Y. J., Raman, G., Bodendiek, S.,
O’Donnell, M. E., and Wulff, H.
(2011). The KCa3.1 blocker TRAM-
34 reduces infarction and neu-
rological deficit in a rat model
of ischemia/reperfusion stroke. J.
Cereb. Blood Flow Metab. 31,
2363–2374.
Coulon, P., Herr, D., Kanyshkova, T.,
Meuth, P., Budde, T., and Pape, H. C.
(2009). Burst discharges in neurons
of the thalamic reticular nucleus
are shaped by calcium-induced cal-
cium release. Cell Calcium 46,
333–346.
Cui, G., Okamoto, T., and Morikawa,
H. (2004). Spontaneous opening of
T-type Ca2+ channels contributes to
the irregular firing of dopamine neu-
rons in neonatal rats. J. Neurosci. 24,
11079–11087.
Deignan, J., Luján, R., Bond, C., Riegel,
A., Watanabe, M., Williams, J.T., et
al. (2012). SK2 and SK3 expression
differentially affect firing frequency
and precision in dopamine neurons.
Neuroscience 217, 67–76.
Dolga, A. M., Granic, I., Blank, T.,
Knaus, H. G., Spiess, J., Luiten,
P. G., et al. (2008). TNF-alpha-
mediates neuroprotection against
glutamate-induced excitotoxicity
via NF-kappaB-dependent up-
regulation of K2.2 channels. J.
Neurochem. 107, 1158–1167.
Dolga, A. M., Letsche, T., Gold, M.,
Doti, N., Bacher, M., Chiamvi-
monvat, N., et al. (2012). Activa-
tion of KCNN3/SK3/K(Ca)2.3 chan-
nels attenuates enhanced calcium
influx and inflammatory cytokine
production in activated microglia.
Glia 60, 2050–2064.
Dolga, A. M., Terpolilli, N., Kepura, F.,
Nijholt, I. M., Knaus, H. G., D’Orsi,
B., et al. (2011). KCa2 channels acti-
vation prevents [Ca2+]i deregulation
and reduces neuronal death follow-
ing glutamate toxicity and cerebral
ischemia. Cell Death Dis. 2, e147.
Dunnett, S. B., and Bjorklund, A.
(1999). Prospects for new restora-
tive and neuroprotective treatments
in Parkinson’s disease. Nature 399,
A32–A39.
Eder, C. (1998). Ion channels in
microglia (brain macrophages). Am.
J. Physiol. 275, C327–C342.
Eder, C., Klee, R., and Heinemann,
U. (1997). Pharmacological prop-
erties of Ca2+-activated K+ cur-
rents of ramified murine brain
macrophages. Naunyn Schmiede-
bergs Arch. Pharmacol. 356, 233–239.
Eriksen, B. L., Teuber, L., Hougaard,
C., and Sørenson, U. S. (2006).
Pyrazolyl-pyrimidines as potas-
sium channel modulating agents
and their medical use. Patent
WO/2006/100212.
Faber, E. S., Delaney, A. J., and Sah, P.
(2005). SK channels regulate excita-
tory synaptic transmission and plas-
ticity in the lateral amygdala. Nat.
Neurosci. 8, 635–644.
Faber, E. S., and Sah, P. (2003). Ca2+-
activated K+ (BK) channel inacti-
vation contributes to spike broad-
ening during repetitive firing in the
rat lateral amygdala. J. Physiol. 552,
483–497.
Fakler, B., and Adelman, J. P. (2008).
Control of KCa channels by cal-
cium nano/microdomains. Neuron
59, 873–881.
Fiorillo, C. D., and Williams, J. T. (1998).
Glutamate mediates an inhibitory
postsynaptic potential in dopamine
neurons. Nature 394, 78–82.
Grace, A. A., and Bunney, B. S. (1984).
The control of firing pattern in
nigral dopamine neurons: burst fir-
ing. J. Neurosci. 4, 2877–2890.
Grace, A. A., and Onn, S. P. (1989).
Morphology and electrophysiologi-
cal properties of immunocytochem-
ically identified rat dopamine neu-
rons recorded in vitro. J. Neurosci. 9,
3463–3481.
Grenhoff, J., Ugedo, L., and Svensson,
T. H. (1988). Firing patterns of
midbrain dopamine neurons: differ-
ences between A9 and A10 cells. Acta
Physiol. Scand. 134, 127–132.
Grunnet, M., Jespersen, T., Angelo, K.,
Frøkjaer-Jensen, C., Klaerke, D. A.,
Olesen,S. P., et al. (2001). Pharmaco-
logical modulation of SK3 channels.
Neuropharmacology 40, 879–887.
Gulledge, A. T., and Stuart, G. J. (2005).
Cholinergic inhibition of neocorti-
cal pyramidal neurons. J. Neurosci.
25, 10308–10320.
Haddock, R. E., and Hill, C. E. (2002).
Differential activation of ion chan-
nels by inositol 1,4,5-trisphosphate
(IP3)- and ryanodine-sensitive cal-
cium stores in rat basilar artery
vasomotion. J. Physiol. (Lond.) 545,
615–627.
Hayashi, Y., Kawaji, K., Sun, L., Zhang,
X., Koyano, K., Yokoyama, T.,
et al. (2011). Microglial Ca(2+)-
activated K(+) channels are pos-
sible molecular targets for the
analgesic effects of S-ketamine on
neuropathic pain. J. Neurosci. 31,
17370–17382.
Herrik, K. F., Redrobe, J. P., Holst, D.,
Hougaard, C., Sandager-Nielsen, K.,
Nielsen, A. N., et al. (2012). CyPPA,
a positive SK3/SK2 modulator,
reduces activity of dopaminergic
neurons, inhibits dopamine
release, and counteracts hyper-
dopaminergic behaviors induced by
methylphenidate. Front. Pharmacol.
3:11. doi:10.3389/fphar.2012.00011
Hirsch, E. C., and Hunot, S. (2009).
Neuroinflammation in Parkinson’s
disease: a target for neuroprotection?
Lancet Neurol. 8, 382–397.
Hoffmann, A., Kann, O., Ohlemeyer,
C., Hanisch, U. K., and Ketten-
mann, H. (2003). Elevation of
basal intracellular calcium as a cen-
tral element in the activation of
brain macrophages (microglia): sup-
pression of receptor-evoked cal-
cium signaling and control of
release function. J. Neurosci. 23,
4410–4419.
Hougaard, C., Eriksen, B. L., Jør-
gensen, S., Johansen, T. H., Dyhring,
T., Madsen, L. S., et al. (2007).
Selective positive modulation of
the SK3 and SK2 subtypes of
small conductance Ca2+-activated
K+ channels. Br. J. Pharmacol. 151,
655–665.
Jager, H., Dreker, T., Buck, A., Giehl,
K., Gress, T., and Grissmer, S.
(2004). Blockage of intermediate-
conductance Ca2+-activated
K+ channels inhibit human
pancreatic cancer cell growth
in vitro. Mol. Pharmacol. 65,
630–638.
Jensen, B. S., Hertz, M., Christo-
phersen, P., and Madsen, L. S. (2002).
The Ca2+-activated K+ channel of
intermediate conductance: a pos-
sible target for immune suppres-
sion. Expert Opin. Ther. Targets 6,
623–636.
Ji, H., Hougaard, C., Herrik, K. F.,
Strøbaek, D., Christophersen, P.,
and Shepard, P. D. (2009). Tun-
ing the excitability of midbrain
dopamine neurons by modulat-
ing the Ca2+ sensitivity of SK
channels. Eur. J. Neurosci. 29,
1883–1895.
Judge, S. I., Smith, P. J., Stewart, P. E.,
and Bever, C. T. Jr. (2007). Potas-
sium channel blockers and open-
ers as CNS neurologic therapeutic
agents. Recent Pat. CNS Drug Discov.
2, 200–228.
Kakizawa, S., Kishimoto, Y., Hashimoto,
K., Miyazaki, T., Furutani, K.,
Shimizu, H., et al. (2007).
Junctophilin-mediated channel
crosstalk essential for cerebellar
synaptic plasticity. EMBO J. 26,
1924–1933.
Kaushal, V., Koeberla, P. D., Wang,
Y., and Schlichter, L. C. (2007).
The Ca2+-activated K+ chan-
nel KCNN4/KCa3.1 contributes
to microglia activation and
nitric oxide-dependent neu-
rodegeneration. J. Neurosci. 27,
234–244.
Kettenmann, H., Hanisch, U. K., Noda,
M., and Verkhratsky, A. (2011).
Physiology of microglia. Physiol.
Rev. 91, 461–553.
Khanna, R., Roy, L., Zhu, X., and
Schlichter, L. C. (2001). K+ chan-
nels and the microglial respiratory
burst. Am. J. Physiol. Cell Physiol.
280, C796–C806.
Klegeris, A., Choi, H. B., McLarnon,
J. G., and McGeer, P. L. (2007).
Functional ryanodine receptors are
expressed by human microglia
and THP-1 cells: their possible
involvement in modulation of neu-
rotoxicity. J. Neurosci. Res. 85,
2207–2215.
Klement, G., Druzin, M., Haage,
D., Malinina, E., Arhem, P., and
Johansson, S. (2010). Spontaneous
ryanodine-receptor-dependent
Ca2+-activated K+ currents and
hyperpolarizations in rat medial
preoptic neurons. J. Neurophysiol.
103, 2900–2911.
Köhler, M., Hirschberg, B., Bond,
C. T., Kinzie, J. M., Marrion,
N. V., Maylie, J., et al. (1996).
Small-conductance, calcium-
activated potassium channels from
mammalian brain. Science 273,
1709–1714.
Köhler, R., Kaistha, B. P., and Wulff,
H. (2010). Vascular KCa-channels
as therapeutic targets in hyper-
tension and restenosis disease.
Expert Opin. Ther. Targets 14,
143–155.
Köhler, R., Wulff, H., Eichler, I.,
Kneifel, M., Neumann, D., Knorr,
A., et al. (2003). Blockade of
www.frontiersin.org November 2012 | Volume 3 | Article 196 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dolga and Culmsee SK/IK channels in microglia and neurons
the intermediate-conductance
calcium-activated potassium chan-
nel as a new therapeutic strategy
for restenosis. Circulation 108,
1119–1125.
Koistinaho, M., and Koistinaho,
J. (2002). Role of p38 and
p44/42 mitogen-activated pro-
tein kinases in microglia. Glia 40,
175–183.
Kuiper, E. F., Nelemans, A., Luiten,
P., Nijholt, I., Dolga, A., and
Eisel, U. (2012). K(Ca)2 and K(Ca)3
channels in learning and mem-
ory processes, and neurodegen-
eration. Front. Pharmacol. 3:107.
doi:10.3389/fphar.2012.00107
Kye, M. J., Spiess, J., and Blank, T.
(2007). Transcriptional regulation
of intronic calcium-activated potas-
sium channel SK2 promoters by
nuclear factor-kappa B and gluco-
corticoids. Mol. Cell. Biochem. 300,
9–17.
Li, W., and Aldrich, R. W. (2011). Elec-
trostatic influences of charged inner
pore residues on the conductance
and gating of small conductance
Ca2+-activated K+ channels.
Proc. Natl. Acad. Sci. U.S.A. 108,
5946–5953.
Liégeois, J. F., Mercier, F., Graulich, A.,
Graulich-Lorge, F., Scuvée-Moreau,
J., and Seutin, V. (2003). Modula-
tion of small conductance calcium-
activated potassium (SK) chan-
nels: a new challenge in medici-
nal chemistry. Curr. Med. Chem. 10,
625–647.
Liu, B. S., Ferreira, R., Lively, S., and
Schlichter, L. C. (2012). Microglial
SK3 and SK4 currents and activa-
tion state are modulated by the neu-
roprotective drug, riluzole. J. Neu-
roimmune Pharmacol. [Epub ahead
of print].
Lu, Z. (2004). Mechanism of rec-
tification in inward-rectifier K+
channels. Annu. Rev. Physiol. 66,
103–129.
Mattson, M. P. (2005). NF-kappaB
in the survival and plasticity of
neurons. Neurochem. Res. 30,
883–893.
Morikawa, H., Imani, F., Khodakhah,
K., and Williams, J. T. (2000).
Inositol 1,4,5-triphosphate-evoked
responses in midbrain dopamine
neurons. J. Neurosci. 20, RC103.
Nagano, T., Kimura, S. H., Takai,
E., Matsuda, T., and Takemura,
M. (2006). Lipopolysaccharide sen-
sitizes microglia toward Ca(2+)-
induced cell death: mode of cell
death shifts from apoptosis to necro-
sis. Glia 53, 67–73.
Ngo-Anh, T. J., Bloodgood, B. L., Lin,
M., Sabatini, B. L., Maylie, J., and
Adelman, J. P. (2005). SK chan-
nels and NMDA receptors form
a Ca2+-mediated feedback loop in
dendritic spines. Nat. Neurosci. 8,
642–649.
Oliver, D., Klocker, N., Schuck, J.,
Baukrowitz, T., Ruppersberg, J. P.,
and Fakler, B. (2000). Gating of
Ca2+-activated K+ channels controls
fast inhibitory synaptic transmission
at auditory outer hair cells. Neuron
26, 595–601.
Pedarzani, P., and Stocker, M. (2008).
Molecular and cellular basis
of small- and intermediate-
conductance, calcium-activated
potassium channel function in
the brain. Cell. Mol. Life Sci. 65,
3196–3217.
Ping, H. X., and Shepard, P. D. (1996).
Apamin-sensitive Ca2+-activated K+
channels regulate pacemaker activity
in nigral dopamine neurons. Neu-
roreport 7, 809–814.
Polazzi, E., and Monti, B. (2010).
Microglia and neuroprotection:
from in vitro studies to therapeutic
applications. Prog. Neurobiol. 92,
293–315.
Power, J. M., and Sah, P. (2008). Com-
petition between calcium-activated
K+ channels determines cholin-
ergic action on firing proper-
ties of basolateral amygdala pro-
jection neurons. J. Neurosci. 28,
3209–3220.
Qian, L., Flood, P. M., and Hong, J. S.
(2010). Neuroinflammation is a key
player in Parkinson’s disease and a
prime target for therapy. J. Neural
Transm. 117, 971–979.
Ristori, G., Romano, S., Visconti,
A., Cannoni, S., Spadaro, M.,
Frontali, M., et al. (2010). Rilu-
zole in cerebellar ataxia: a ran-
domized, double-blind, placebo-
controlled pilot trial. Neurology 74,
839–845.
Rupalla, K., Allegrini, P. R., Sauer,
D., and Wiessner, C. (1998). Time
course of microglia activation and
apoptosis in various brain regions
after permanent focal cerebral
ischemia in mice. Acta Neuropathol.
96, 172–178.
Sabatini, B. L., Oertner, T. G., and Svo-
boda, K. (2002). The life cycle of
Ca2+ ions in dendritic spines. Neu-
ron 33, 439–452.
Sailer, C. A., Kaufmann, W. A.,
Marksteiner, J., and Knaus, H. G.
(2004). Comparative immunohis-
tochemical distribution of three
small-conductance Ca2+-activated
potassium channel subunits,
SK1, SK2, and SK3 in mouse
brain. Mol. Cell. Neurosci. 26,
458–469.
Sarpal, D., Koenig, J. I., Adelman, J. P.,
Brady, D., Prendeville, L. C., and
Shepard, P. D. (2004). Regional dis-
tribution of SK3 mRNA-containing
neurons in the adult and ado-
lescent rat ventral midbrain and
their relationship to dopamine-
containing cells. Synapse 53,
104–113.
Schlichter, L. C., Kaushal, V., Moxon-
Emre, I., Sivagnanam, V., and Vin-
cent, C. (2010). The Ca2+ acti-
vated SK3 channel is expressed in
microglia in the rat striatum and
contributes to microglia-mediated
neurotoxicity in vitro. J. Neuroin-
flammation 7, 4.
Seutin, V., Mkahli, F., Massotte, L.,
and Dresse, A. (2000). Calcium
release from internal stores is
required for the generation of
spontaneous hyperpolarizations
in dopaminergic neurons of
neonatal rats. J. Neurophysiol. 83,
192–197.
Skaper, S. D. (2011). Ion channels
on microglia: therapeutic tar-
gets for neuroprotection. CNS
Neurol. Disord. Drug Targets 10,
44–56.
Sørensen, U. S., Teuber, L., Peters,
D., Stroebaek, D., Johansen, T. H.,
Nielsen, K. S., et al. (2006a). Novel
2-amino benzimidalzole deriva-
tives and their use as modulators
of small conductance calcium-
activated potassium channels.
Patent WO/2006/074991.
Sørensen, U. S., Teuber, L., Peters,
D., Stroebaek, D., Johansen, T.
H., Nielsen, K. S., et al. (2006b).
2-(phenylamino)benzimidalzole
derivatives and their use as mod-
ulators of small conductance
calcium-activated potassium
channels. Patent WO/2006/136580.
Spanagel, R., and Weiss, F. (1999). The
dopamine hypothesis of reward: past
and current status. Trends Neurosci.
22, 521–527.
Stocker, M. (2004). Ca2+-activated
K+ channels: molecular determi-
nants and function of the SK
family. Nat. Rev. Neurosci. 5.
758–770.
Strøbaek, D., Hougaard, C., Johansen,
T. H., Sørensen, U. S., Nielsen,
E. Ø., Nielsen, K. S., et al.
(2006). Inhibitory gating mod-
ulation of small conductance
Ca2+-activated K+ channels
by the synthetic compound
(R)-N-(benzimidazol-2-yl)-
1,2,3,4-tetrahydro-1-naphtylamine
(NS8593) reduces afterhyper-
polarizing current in hippocampal
CA1 neurons. Mol. Pharmacol. 70,
1771–1782.
Strøbaek, D., Teuber, L., Jørgensen, T.
D., Ahring, P. K., Kjaer, K., Hansen,
R. S., et al. (2004). Activation of
human IK and SK Ca2+-activated K+
channels by NS309 (6,7-dichloro-
1H-indole-2,3-dione 3-oxime).
Biochim. Biophys. Acta 1665,
1–5.
Svensson, T. H. (2000). Dysfunc-
tional brain dopamine systems
induced by psychotomimetic
NMDA-receptor antagonists and
the effects of antipsychotic drugs.
Brain Res. Brain Res. Rev. 31,
320–329.
Tanabe, M., Mori, M., Gähwiler, B. H.,
and Gerber, U. (1999). Apamin-
sensitive conductance mediates
the K(+) current response during
chemical ischemia in CA3 pyra-
midal cells. J. Neurophysiol. 82,
2876–2882.
Varas-Lorenzo, C., Riera-Guardia, N.,
Calingaert, B., Castellsague, J., Pari-
ente, A., Scotti, L., et al. (2011).
Stroke risk and NSAIDs: a system-
atic review of observational studies.
Pharmacoepidemiol. Drug Saf. 20,
1225–1236.
Verkhratsky, A., and Kettenmann,
H. (1996). Calcium signalling in
glial cells. Trends Neurosci. 19,
346–352.
Virgili, N., Espinosa-Parrilla, J. F.,
Mancera, P., Pastén-Zamorano, A.,
Gimeno-Bayon, J., Rodríguez, M. J.,
et al. (2011). Oral administration
of the KATP channel opener dia-
zoxide ameliorates disease progres-
sion in a murine model of multi-
ple sclerosis. J. Neuroinflammation 8,
149.
Walter, J. T., Alvina, K., Womack,
M. D., Chevez, C., and Kho-
dakhah, K. (2006). Decreases in
the precision of Purkinje cell pace-
making cause cerebellar dysfunc-
tion and ataxia. Nat. Neurosci. 9,
389–397.
Wang, X., Fulp, A. B., van Rhee, A.
M., and Spear, K. L. (2003). Bis-
benzimidazoles and related com-
pounds as potassium channel mod-
ulators. Patent WO/2003/094861.
Waubant, E. (2007). Neuroprotec-
tion with riluzole in patients
with early multiple sclerosis. Patent
NCT00501943.
Whitton, P. S. (2010). Neuroin-
flammation and the prospects
for anti-inflammatory treat-
ment of Parkinson’s disease.
Curr. Opin. Investig. Drugs 11,
788–794.
Wilson, C. J., Young, S. J., and Groves,
P. M. (1977). Statistical proper-
ties of neuronal spike trains in
the substantia nigra: cell types and
Frontiers in Pharmacology | Neuropharmacology November 2012 | Volume 3 | Article 196 | 8
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dolga and Culmsee SK/IK channels in microglia and neurons
their interactions. Brain Res. 136,
243–260.
Wolfart, J., Neuhoff, H., Franz,
O., and Roeper, J. (2001).
Differential expression of the small-
conductance, calcium-activated
potassium channel SK3 is critical for
pacemaker control in dopaminergic
midbrain neurons. J. Neurosci. 21,
3443–3456.
Wulff, H., Calabresi, P. A., Allie, R., Yun,
S., Pennington, M., Beeton, C., et al.
(2003). The voltage-gated Kv1.3 K+
channel in effector memory T cells as
new target for MS. J. Clin. Invest. 111,
1703–1713.
Wulff, H., Kolski-Andreaco, A.,
Sankaranarayanan, A., Sabatier, J.
M., and Shakkottai, V. (2007).
Modulators of small- and
intermediate-conductance calcium-
activated potassium channels and
their therapeutic indications. Curr.
Med. Chem. 14, 1437–1457.
Wulff, H., Miller, M. J., Hansel, W.,
Grissmer, S., Cahalan, M. D., and
Chandy, K. G. (2000). Design of
a potent and selective inhibitor
of the intermediate-conductance
Ca2+-activated K+ channel, IKCa1:
a potential immunosuppressant.
Proc. Natl. Acad. Sci. U.S.A. 97,
8151–8156.
Wyss-Coray, T., and Mucke, L. (2000).
Ibuprofen, inflammation and
Alzheimer’s disease. Nat. Med. 6,
973–974.
Xia, X. M., Fakler, B., Rivard, A.,
Wayman, G., Johnson-Pais, T., Keen,
J. E., et al. (1998). Mechanism
of calcium gating in small-
conductance calcium-activated
potassium channels. Nature 395,
503–507.
Yan, Q., Zhang, J., Liu, H., Babu-
Khan, S., Vassar, R., Biere, A. L.,
et al. (2003). Anti-inflammatory
drug therapy alters beta-amyloid
processing and deposition in an
animal model of Alzheimer’s
disease. J. Neurosci. 23,
7504–7509.
Yanovsky, Y., Zhang, W., and Misgeld,
U. (2005). Two pathways for the
activation of small-conductance
potassium channels in neu-
rons of substantia nigra pars
reticulata. Neuroscience 136,
1027–1036.
Zhou, F., Yao, H. H., Wu, J. Y.,
Ding, J. H., Sun, T., and Hu, G.
(2008). Opening of microglial
KATP channels inhibits rotenone-
induced neuroinflammation.
J. Cell. Mol. Med. 12,
1559–1570.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 09 March 2012; accepted: 01
November 2012; published online: 26
November 2012.
Citation: Dolga AM and Culmsee C
(2012) Protective roles for potassium
SK/KCa2 channels in microglia and
neurons. Front. Pharmacol. 3:196. doi:
10.3389/fphar.2012.00196
This article was submitted to Frontiers
in Neuropharmacology, a specialty of
Frontiers in Pharmacology.
Copyright © 2012 Dolga and Culm-
see. This is an open-access article dis-
tributed under the terms of the Cre-
ative Commons Attribution License,
which permits use, distribution and
reproduction in other forums, provided
the original authors and source are
credited and subject to any copyright
notices concerning any third-party
graphics etc.
www.frontiersin.org November 2012 | Volume 3 | Article 196 | 9
